Enlivex Therapeutics
ENLV
ENLV
6 hedge funds and large institutions have $4.49M invested in Enlivex Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
4
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.09M |
2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.81M |
3 |
Renaissance Technologies
New York
|
+$265K |
4 |
Morgan Stanley
New York
|
+$132K |
5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$22K |
Top Sellers
1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$323K |
2 |
UBS Group
Zurich,
Switzerland
|
-$24K |
3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |